Ładuje się......
Targeting MDMX for Cancer Therapy: Rationale, Strategies, and Challenges
The oncogene MDMX, also known as MDM4 is a critical negative regulator of the tumor suppressor p53 and has been implicated in the initiation and progression of human cancers. Increasing evidence indicates that MDMX is often amplified and highly expressed in human cancers, promotes cancer cell growth...
Zapisane w:
| Wydane w: | Front Oncol |
|---|---|
| Główni autorzy: | , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Frontiers Media S.A.
2020
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7419686/ https://ncbi.nlm.nih.gov/pubmed/32850448 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01389 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|